Pheonix-Based Cardiology Group Continues to Expand Access to Care Across ValleyPHOENIX, Dec. 26, 2025 /PRNewswire/ -- ...

Sarawak has reached a new milestone in advanced cardiac care with the successful completion of the first EPi-Sense hybrid ...

Abbott has announced the company has received approval from the U.S. Food and Drug Administration (FDA) for its Volt PFA ...

The Volt pulsed-field ablation (PFA) system (Abbott) has been approved by the US Food and Drug Administration for the treatment of patients with atrial fibrillation (AF), according to a Monday ...

Other hot topics included new data on LAAO and conduction-system pacing, plus the go-ahead for ablation in ASCs.

US FDA approves Abbott's Volt PFA System to treat patients with atrial fibrillation: Abbott Park, Illinois Wednesday, December 24, 2025, 12:00 Hrs [IST] Abbott, is a global health ...

Medtronic tops the list of the largest cardio device companies, with cardiovascular technology proving a major growth driver.

The King Abdullah University Hospital (KAUH) has performed its first catheter-based cardiac ablation procedures for the treatment of cardiac arrhythmias, using advanced electrophysiology and cardiac ...

Abbott will soon enter the competitive U.S. pulsed field ablation (PFA) market, having just received FDA approval for its ...

The FDA approved Abbott's Volt PFA System for atrial fibrillation, supported by VOLT-AF trial data showing strong safety and ...

Abbott can now compete with Medtronic, Boston Scientific and J&J in the U.S. for the fast-growing pulsed field ablation ...

After claiming its approval in Europe earlier this year, Abbott has secured the FDA’s go-ahead for its Volt pulsed field ablation system for irregular heart rhythms, a step forward in an | With the U.